Prior to this, Neuberger Berman, a New York-based investment management firm slashed PharmEasy’s valuation by 21 per cent to 4.4 billion as of February 28
The edtech raised $250 million from US-based investment firm Davidson Kempner, which is part of the $1 billion funding round it hopes to close this month